Results 171 to 180 of about 71,938 (313)

Comprehensive Profiling of Annexins in Neuromuscular Disorders Reveals a Unique Signature in Dysferlinopathy

European Journal of Neurology, Volume 32, Issue 12, December 2025.
Muscle biopsies from patients across eight neuromuscular disorders and healthy controls were analyzed using immunofluorescence (IF) and immunoblot (WB) to evaluate the expression and localization of seven annexin proteins (A1, A2, A4, A5, A6, A7, A11).
Qi‐Fang He, Yu‐hua Lin, Ze‐ling Zheng, Ming‐hui Zeng, Xin Lin, Xin‐yi Liu, Kang‐yang, Q I‐jie Zhang, Min‐ting Lin, Ning Wang, Zhi‐qiang Wang, Feng Lin   +11 more
wiley   +1 more source

Exploring the respiratory efficacy of combined chronic glucocorticoid and antioxidant interventions in the mdx mouse: The PREDNAC trial

Experimental Physiology, Volume 110, Issue 12, Page 2019-2035, December 1, 2025.
Abstract Duchenne muscular dystrophy (DMD) is characterized by respiratory muscle injury and weakness, ultimately leading to respiratory failure. Impaired respiratory muscle performance, fibrosis and inflammation in early disease are evident in the dystrophin‐deficient mdx mouse model of DMD.
Michael N. Maxwell, Ben T. Murphy, Fiona B. McDonald, Ken D. O'Halloran   +3 more
wiley   +1 more source

830. Highly Efficient and Comprehensive Gene Transfer to All Muscle Groups Necessary for the Potential Treatment of Duchenne/Becker Muscular Dystrophies Following In Utero Delivery of a Lentivirus Vector in Immuno-Competent Mice [PDF]

, 2003

openalex   +1 more source

Genetic strategies for therapy of Duchenne muscular dystrophy. [PDF]

Mol Ther Nucleic Acids
Łoboda A, Chamberlain JS, Dulak J.
europepmc   +1 more source

Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy

, 2014
Paul M.L. Janssen, Jason D. Murray, Kevin E. Schill, Neha Rastogi, Eric J. Schultz, Tam Tran, Subha V. Raman, Jill A. Rafael‐Fortney   +7 more
openalex   +2 more sources

Glycosaminoglycan Modifications in Duchenne Muscular Dystrophy [PDF]

, 2014
Elisa Négroni, Emilie Hénault, Fabien Chevalier, Marie Gilbert-Sirieix, Toin H. Van Kuppevelt, Dulce Papy-García, Georges Uzan, Patricia Albanese   +7 more
openalex   +1 more source

Weighted cart pull: A novel outcome measure for sustained motor function in mice

Experimental Physiology, Volume 110, Issue 12, Page 1978-1989, December 1, 2025.
Abstract Sarcopenia, the pathological age‐related decline in muscle mass and strength, compromises independence and quality of life in older adults. Currently, no effective treatments are available. To enhance translational research using aged mouse models, we developed and validated the weighted cart pull (WCP) as a novel assessment of sustained motor
Charles D. Brennan, Nathan R. Kerr, Jose A. Viteri, Zachary Williard, Harper Snyder, Gabriella Meier, Sam Cairns, Fereshteh B. Darvishi, Anna R. Dashtmian, Peter J. Moore, Sindhuja N. Ayyagari, Meifang Wang, W. David Arnold   +12 more
wiley   +1 more source

Epicardial Adipose Tissue in Duchenne Muscular Dystrophy Cardiomyopathy. [PDF]

J Am Heart Assoc
Greiner E, Miles KG, Gao Z, Lang SM, Ryan TD, Ollberding NJ, Mantell BS, Rutter MM, Tian C, Villa CR.   +9 more
europepmc   +1 more source

Perindopril preserves left ventricular function in X-linked Duchenne muscular dystrophy [PDF]

, 2007
Denis Duboc, Christophe Meune, Bertrand Pierre, Karim Wahbi, B. Eymard, Annick Toutain, C. Bérard, Guy Vaksmann, Henri-Marc Bécane   +8 more
openalex   +1 more source

Burden of Duchenne muscular dystrophy in Australia: a scoping review. [PDF]

BMJ Neurol Open
Lee E, Choi S, Kim H.
europepmc   +1 more source